Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8 <sup>+</sup> T cell trafficking
David J. Taggart(ID Genomics (United States)), Mihaela Lorger(University of Leeds), Jennifer M. Williams(South African Medical Research Council), Tereza Andreou(University of Leeds), Nora Rippaus(University of Leeds), Elizabeth J. Ilett(University of Leeds), Alan Melcher(University College Hospital), Karen J. Scott(University of Leeds), Robert J. Salmond(University of Leeds), Rebecca J. Brownlie(University of Leeds)
Cited by 209
Related Papers
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
|Cancer Cell|2018|591
Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
|American Journal Of Pathology|2010|353
Activation of tumor cell integrin α <sub>v</sub> β <sub>3</sub> controls angiogenesis and metastatic growth in the brain
|Proceedings of the National Academy of Sciences|2009|185
Distinct cell-specific control of autoimmunity and infection by FcγRIIb
|The Journal of Experimental Medicine|2008|164
An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation
|Cell stem cell|2010|134